A decade on from the U.S. Supreme Court’s decision in Association for Molecular Pathology v. Myriad Genetics, Inc., Professor Jacob Sherkow argues that what seemed like a political and cultural phenomenon has had a much narrower impact. Writing as the first author in a new paper published in Annual Review of Genomics and Human Genetics, […]
The patent battle over CRISPR-Cas9 technology has gone on for longer than a decade, but continues to wind its way through the courts. The global CRISPR-Cas9 gene-editing market size is expected to grow to $14.65 billion by 2032, and Professor Jacob Sherkow told BioSpace that companies seeking to license the technology may be content to […]
The practice of using “patent thickets,” which allow pharmaceutical companies to delay low-cost generic medicines reaching the market, is being targeted by a rule change proposed by the U.S. Patent and Trademark Office. The change would reduce the number of terminal disclaimers, an important part of patent thickets, which offers the potential to speed the […]
Whether or not DNA sequences are subject to trade secrecy protections is the critical question examined by Professor Jacob Sherkow in his latest article, published in the Hastings Law Journal. Despite decades of scholarship assuming DNA sequences would be subject to protection, recent research has suggested this assumption was incorrect. Sherkow explores why DNA sequences […]
Professor Jacob Sherkow is one of only five University of Illinois Urbana-Champaign professors to be named a University Scholar in recognition of his excellence in teaching, scholarship and service. The scholars program recognizes faculty excellence and provides $15,000 to each scholar for three years to enhance their academic careers. The money may be used for […]
Professor Jacob Sherkow is one of the authors of a chapter in the new book “COVID-19 and the Law,” published by Cambridge University Press. The chapter examines the ways in which aspects of health law such as food and drug regulation, healthcare reimbursement, and direct research and development subsidies encouraged and impeded new technologies in […]
The dispute over who invented CRISPR-Cas9 gene editing is headed to federal appellate court, and Politico turned to Professor Jacob Sherkow to help sort out the details. He expects the case will return to patent court and may result in changes to the licensing fees collected. “Absolutely none of this under any reasonable interpretation is […]
Illinois Law professor and IP expert Jacob Sherkow spoke to Nature Biotechnology about the recent Tome Biosciences acquisition of Replace Therapeutics to enhance their gene editing capabilities. The article discusses the surge of prime editing deals in biotechnology as companies seek to secure patent rights and avoid intellectual property conflicts. The industry is seeing mergers […]
Professor Jacqueline E. Ross was awarded the 2024 Wayne R. LaFave Award for Scholarly Excellence for her book “Making Sense of Youth Crime: A Comparison of Police Intelligence in the United States and France,” (Cambridge University Press, 2023) co-authored with Thierry Delpeuch of the French National Centre for Scientific Research. This award was established in […]
The famous system of breaking down legal analyses into ordered subparts, Issue-Rule-Analysis-Conclusion, needs an updated focus on the last part, according to Professor Jacob Sherkow. In his new paper, available for download on SSRN, he argues that lawyers need to be experts in conclusions, writing “good conclusions – clear, reasonable, workable, plausible, probable conclusions – […]